Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 11/20 | 0.69 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | PNMT | P11086 | 1/20 | 0.31 |
| ▸ | SMAD3 | P84022 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29488626 | 1.00 | AHR (0.69) | AHRTSHRCYP1A2CYP2A6LMNA | |
| SCHEMBL2461013 | 0.89 | AHR (0.56) | AHRTSHR | |
| SCHEMBL9579668 | 0.89 | — | — | |
| SCHEMBL2464333 | 0.87 | AHR (0.58) | AHRTSHR | |
| SCHEMBL5588344 | 0.86 | AHR (0.62) | AHRTSHRCYP1A2CYP2A6SMAD3 | |
| Ethane SCHEMBL28414050 | 0.84 | AHR (0.78) | AHRTSHRCYP1A2CYP2A6LMNA | |
| SCHEMBL1580478 | 0.82 | AHR (1.00) | AHRTSHRCYP1A2CYP2A6LMNA | |
| SCHEMBL7064518 | 0.80 | AHR (0.95) | AHRTSHRCYP1A2CYP2A6LMNA | |
| SCHEMBL2463391 | 0.79 | AHR (0.59) | AHR | |
| SCHEMBL6254624 | 0.79 | AHR (0.64) | AHRTSHRCYP1A2CYP2A6LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021145798-A2 | METHODS OF BIOLOGICAL AGE EVALUATION AND SYSTEMS USING SUCH METHODS | OBSHCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIU "GERO" (RU) | 2021-07-22 | — | — | WO | claimed |
| US-20100267829-A1 | Pharmaceutical composition comprising low concentrations of environment pollutants | PRONOVA BIOPHARMA NORGE | 2010-10-21 | — | — | US | claimed |
| US-20100233281-A1 | PROCESS FOR DECREASING ENVIRONMENTAL POLLUTANTS IN AN OIL OR A FAT. | PRONOVA BIOPHARMA NORGE AS | 2010-09-16 | — | — | US | claimed |
| US-20070108391-A1 | Method of analyzing dioxins | KABUSHIKI KAISHA IDX TECHNOLOGIES (JP) | 2007-05-17 | — | — | US | claimed |
| CN-1710100-A | Method for high-flux detecting environmental dioxin-like chemical substances | WUHAN VIRUS INST CHINESE ACADE (CN) | 2005-12-21 | — | — | CN | claimed |
| EP-0859949-A4 | PROCESS FOR EXTRACTING COMPOUNDS FROM SAMPLE MATRICES | TRIANGLE LAB INC (US) | 2000-03-29 | — | — | EP | claimed |
| EP-0859949-A1 | PROCESS FOR EXTRACTING COMPOUNDS FROM SAMPLE MATRICES | Triangle Laboratories Inc. (US) | 1998-08-26 | — | — | EP | claimed |
| WO-1997017601-A1 | PROCESS FOR EXTRACTING COMPOUNDS FROM SAMPLE MATRICES | TRIANGLE LABORATORIES, INC. (US) | 1997-05-15 | — | — | WO | claimed |
| US-12622925-B2 | Edible enterosorbents used to mitigate acute exposures to ingestible environmental toxins following outbreaks, natural disasters and emergencies | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2026-05-12 | — | — | US | disclosed |
| CN-110914395-B | Method for preparing hydrogenated fat composition | 邦吉洛德斯克罗科兰有限公司 | 2023-07-07 | — | — | CN | disclosed |
| US-20230183165-A1 | HIGHLY UNSATURATED FATTY ACID OR HIGHLY UNSATURATED FATTY ACID ETHYL ESTER WITH REDUCED ENVIRONMENTAL POLLUTANTS, AND METHOD FOR PRODUCING SAME | NISSUI CORPORATION (JP) | 2023-06-15 | — | — | US | disclosed |
| US-11603347-B2 | Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same | NIPPON SUISAN KAISHA, LTD. (JP) | 2023-03-14 | — | — | US | disclosed |
| EP-3649219-B1 | PROCESS FOR THE PREPARATION OF A HYDROGENATED FAT COMPOSITION | BUNGE LODERS CROKLAAN B V (NL) | 2022-10-05 | — | — | EP | disclosed |
| US-20220024787-A1 | METHOD AND APPARATUS FOR COPPER-CATALYZED ELECTROCHEMICAL WATER TREATMENT | Cape Breton University (CA) | 2022-01-27 | — | — | US | disclosed |
| US-5356604-A | Using Caro*s acid | DEGUSSA AKTIENGESELLSCHAFT (DE) | 1994-10-18 | — | — | US | disclosed |
| US-5304702-A | REACTING WITH STRONGLY BASIC HYDROCARBON-SOLUBLE LITHIUM COMPOUND | METALLGESELLSCHAFT AG (DE) | 1994-04-19 | — | — | US | disclosed |
| US-5254797-A | Pollution control | NGK INSULATORS, LTD. (JP) | 1993-10-19 | — | — | US | disclosed |
| EP-0546314-A1 | Method for removing halogenated organic compounds from flue gases | DEGUSSA AG (DE) | 1993-06-16 | — | — | EP | disclosed |
| EP-0447537-A1 | PROCESS FOR REDUCING THE EMISSION OF ORGANIC COMPOUNDS PRODUCED BY INCOMPLETE COMBUSTION. | BABCOCK IND AG (DE) | 1991-09-25 | — | — | EP | disclosed |
| WO-1991004780-A1 | PROCESS FOR REDUCING THE EMISSION OF ORGANIC COMPOUNDS PRODUCED BY INCOMPLETE COMBUSTION | BABCOCK DEUTSCHE BABCOCK ANLAGEN AG (DE) | 1991-04-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12622925-B2 | Edible enterosorbents used to mitigate acute exposures to ingestible environmental toxins following outbreaks, natural disasters and emergencies | FABP2, LCT, DDT | AHR 147/4885TSHR 755/4885CYP1A2 2950/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.